Virtus ETF Advisers’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,099
| Closed | -$70.6K | – | 266 |
|
|
2024
Q4 | $70.6K | Sell |
24,099
-3,579
| -13% | -$10.5K | 0.03% | 373 |
|
|
2024
Q3 | $72K | Buy |
27,678
+493
| +2% | +$1.28K | 0.03% | 425 |
|
|
2024
Q2 | $80.5K | Buy |
27,185
+11,373
| +72% | +$33.7K | 0.04% | 404 |
|
|
2024
Q1 | $71.6K | Sell |
15,812
-1,082
| -6% | -$4.9K | 0.04% | 409 |
|
|
2023
Q4 | $96.5K | Buy |
16,894
+3,509
| +26% | +$20K | 0.06% | 374 |
|
|
2023
Q3 | $61.6K | Sell |
13,385
-1,329
| -9% | -$6.11K | 0.04% | 402 |
|
|
2023
Q2 | $95.1K | Buy |
14,714
+4,731
| +47% | +$30.6K | 0.06% | 409 |
|
|
2023
Q1 | $75.3K | Sell |
9,983
-3,844
| -28% | -$29K | 0.04% | 394 |
|
|
2022
Q4 | $140K | Buy |
13,827
+1,951
| +16% | +$19.8K | 0.07% | 366 |
|
|
2022
Q3 | $117K | Buy |
11,876
+92
| +0.8% | +$906 | 0.05% | 401 |
|
|
2022
Q2 | $125K | Hold |
11,784
| – | – | 0.05% | 369 |
|
|
2022
Q1 | $115K | Sell |
11,784
-698
| -6% | -$6.81K | 0.05% | 278 |
|
|
2021
Q4 | $178K | Buy |
12,482
+3,818
| +44% | +$54.4K | 0.07% | 252 |
|
|
2021
Q3 | $174K | Sell |
8,664
-447
| -5% | -$8.98K | 0.08% | 301 |
|
|
2021
Q2 | $200K | Buy |
+9,111
| New | +$200K | 0.08% | 346 |
|